Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
27 November 2018 | Story Lacea Loader | Photo Sonia Small
Prof Francis Petersen
Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.
On 24 October 2018, the Board of Universities South Africa (USAf) elected Prof Francis Petersen, Rector and Vice-Chancellor of the University of the Free State (UFS), as Chairperson of its Finance and Investment Committee. As Chairperson of this committee, Prof Petersen will also serve as member of USAf’s Executive Committee and as ordinary member on the Audit and Risk Committee.

“On behalf of the UFS Council, I wish to congratulate Prof Petersen on his election as Chairperson. USAf plays an important role in higher education and I am confident that Prof Petersen’s contribution as Chairperson of the Finance and Investment Committee will be of great value to not only USAf, but to the sector in general,” said Mr Willem Louw, Chairperson of the UFS Council.

According to Prof Petersen, his election as Chairperson and his membership of the Executive Committee and the Audit and Risk Committee will enable him to gain further insight into matters of national interest relating to finance and investment and it will give him the opportunity to represent USAf in its deliberations with government on the broader issue of fees and other related matters. “I am honoured by the election and look forward to support USAf’s initiatives relating to the portfolio,” he said.

Prof Petersen’s appointment as Chairperson of the Finance and Investment Committee is for a three-year term of office.

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept